Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members and maintain the reputation of the sector.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Head of Science and Technology Strategy

About the Wellcome Genome Campus

WGCL is the owner, operator and developer of the Wellcome Genome Campus, which is located nine miles south of Cambridge, within an established life science cluster and ecosystem. WGCL and the Campus are owned by a world-renowned endowment fund that is committed to expanding its existing campus into a global centre for genomics, biodata sciences and associated technologies.

Bionow BioInsight Conference 2026

BioInsight: Exploring Ideas, Enabling Impact

BioInsight is a new conference by Bionow which brings together the life sciences community of Scotland and beyond to share insights, technological and business developments and forge valuable new connections.

With a focus on translating and commercialising new technologies, BioInsight will explore the trends, technologies and collaborations shaping the future of the sector.

Research Associate (Fixed Term)

Applications are invited for an enthusiastic and motivated Research Associate to join the Laboratory of David Owen and Bernard Kelly at the Cambridge Institute for Medical Research. Our work combines cell biology, structural biology and biochemistry/biophysics to build a deep, integrated understanding of intracellular trafficking mechanisms, with a particular emphasis on cargo sorting in the endocytic system. The successful candidate will study the cell biology of receptor trafficking between the plasma membrane and endosomes.

PhoreMost Announces Lead Oncology Programme and Appoints Chief Medical Officer to Support Clinical Entry

·       Next-generation small molecule microtubule targeting agent, PMC-001, progressing towards Phase 1

·       Comprehensive preclinical data package demonstrates differentiating oral activity and CNS penetration, unlocking treatment of primary and secondary brain cancers

·       Dr Gabriel Fox appointed as Chief Medical Officer to lead clinical development

BioDuro Webinar : Choosing the Right Crystal: Solid Form Optimization for Pharmaceutical Development

June 10, 2026 | 23:00 pm GMT+8

Chemical entities can be packed in different three-dimensional arrangements through various intermolecular interactions, resulting in multiple crystalline forms with distinct properties. In pharmaceutical development, these solid forms can directly influence drug performance and intellectual property strategy, making solid-state selection a critical consideration in early-stage development.

Subscribe to